BG108144A - Ново приложение - Google Patents

Ново приложение

Info

Publication number
BG108144A
BG108144A BG108144A BG10814403A BG108144A BG 108144 A BG108144 A BG 108144A BG 108144 A BG108144 A BG 108144A BG 10814403 A BG10814403 A BG 10814403A BG 108144 A BG108144 A BG 108144A
Authority
BG
Bulgaria
Prior art keywords
prevention
nsaid
gastric ulcer
induced gastric
treatment
Prior art date
Application number
BG108144A
Other languages
English (en)
Inventor
Arne Eek
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0100798A external-priority patent/SE0100798D0/xx
Priority claimed from SE0103291A external-priority patent/SE0103291D0/xx
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of BG108144A publication Critical patent/BG108144A/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BG108144A 2001-03-08 2003-09-01 Ново приложение BG108144A (bg)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0100798A SE0100798D0 (sv) 2001-03-08 2001-03-08 New use
SE0103291A SE0103291D0 (sv) 2001-10-03 2001-10-03 New use
PCT/SE2002/000375 WO2002069968A1 (en) 2001-03-08 2002-03-05 New use

Publications (1)

Publication Number Publication Date
BG108144A true BG108144A (bg) 2004-09-30

Family

ID=26655407

Family Applications (1)

Application Number Title Priority Date Filing Date
BG108144A BG108144A (bg) 2001-03-08 2003-09-01 Ново приложение

Country Status (15)

Country Link
US (2) US20040082605A1 (bg)
EP (1) EP1370261A2 (bg)
JP (1) JP2004520422A (bg)
KR (1) KR100904599B1 (bg)
CN (1) CN1496259A (bg)
BG (1) BG108144A (bg)
BR (1) BR0207762A (bg)
CA (1) CA2440100A1 (bg)
CZ (1) CZ20032398A3 (bg)
EE (1) EE05234B1 (bg)
IL (1) IL157461A0 (bg)
MX (1) MXPA03007888A (bg)
NO (1) NO20033919L (bg)
SK (1) SK10982003A3 (bg)
WO (1) WO2002069968A1 (bg)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6852739B1 (en) * 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
CA2493618A1 (en) * 2002-08-01 2004-02-12 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
MXPA05003058A (es) * 2002-09-19 2005-05-27 Schering Corp Nuevas imidazopiridinas como inhibidores de cinasa dependientes de ciclina.
US7151104B2 (en) * 2002-09-19 2006-12-19 Schering Corporation Pyrazolopyridines as cyclin dependent kinase inhibitors
CA2515676A1 (en) * 2003-02-17 2004-08-26 Altana Pharma Ag Imidazopyridines containing combinations and their use in treating gastrointestinal inflammatory disorders
WO2011102460A1 (ja) * 2010-02-19 2011-08-25 学校法人関西医科大学 胃潰瘍の予防又は治療剤、経口投与薬、及び胃潰瘍の予防又は治療剤の製造方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT290523B (de) * 1962-01-05 1971-06-11 Merck & Co Inc Verfahren zur Herstellung neuer α-(3-Indolyl)-carbonsäuren
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
DE3269604D1 (en) * 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
DE3922387A1 (de) * 1989-07-07 1991-01-17 Kali Chemie Pharma Gmbh N-benzyl-n-((1s,5s)-6,6-dimethylbicyclo/3.1.1/hept-2-ylaethoxy-aethyl)-morpholinium-salze enthaltende gastroprotektiv wirksame pharmazeutische zubereitungen
NZ235877A (en) * 1989-11-02 1992-09-25 Mcneil Ppc Inc Composition comprising acetaminophen or nsaid and an h 1 or h 2 receptor blocker and/or proton pump inhibitor for treating overindulgence
KR920002148A (ko) * 1990-07-03 1992-02-28 안드레아 엘. 콜비 비스테로이드계 소염제에 의해 유발된 위장 증상을 완화시키기 위한 약제 조성물 및 이를 완화시키는 방법
ES2130152T3 (es) * 1991-12-06 1999-07-01 Glaxo Group Ltd Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.
EP0971922B1 (en) * 1997-03-24 2004-04-28 ALTANA Pharma AG Tetrahydropyrido compounds
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
DE69905178T2 (de) * 1998-09-23 2003-07-17 Altana Pharma Ag Tetrahydropyridoether
PT1173439E (pt) * 1999-04-17 2003-10-31 Altana Pharma Ag Haloalcoxi imidazonaftiridinas

Also Published As

Publication number Publication date
JP2004520422A (ja) 2004-07-08
KR20040007461A (ko) 2004-01-24
US20040082605A1 (en) 2004-04-29
WO2002069968A8 (en) 2003-04-17
CZ20032398A3 (cs) 2004-02-18
NO20033919D0 (no) 2003-09-04
KR100904599B1 (ko) 2009-06-25
BR0207762A (pt) 2004-06-01
MXPA03007888A (es) 2003-12-04
NO20033919L (no) 2003-09-04
IL157461A0 (en) 2004-03-28
CN1496259A (zh) 2004-05-12
EE200300434A (et) 2003-12-15
CA2440100A1 (en) 2002-09-12
EP1370261A2 (en) 2003-12-17
US20090170854A1 (en) 2009-07-02
WO2002069968A1 (en) 2002-09-12
SK10982003A3 (sk) 2004-02-03
EE05234B1 (et) 2009-12-15

Similar Documents

Publication Publication Date Title
HUP0401998A2 (hu) PDE9 inhibitorok alkalmazása olyan gyógyszer előállítására, amellyel inzulin-rezisztencia szindróma és 2-es típusú diabétesz kezelhető
GEP20053673B (en) Aryl or Heteroaryl Fused Imidazole Compounds as Anti-Inflammatory and Analgesic Agents
SE9804314D0 (sv) New pharmaceutical formulation
EE200200086A (et) Reniin-angiotensiini süsteemi inhibiitori kasutamine, kombineeritud produkt ja meetod kardiovaskulaarsete haigusjuhtude ärahoidmiseks
TR200002207T1 (tr) Slekoksib bileşikleri.
UA88523C2 (ru) Фармацевтический препарат рофлумиласта для местного применения
GEP20063799B (en) Tropane derivatives useful in therapy
MXPA04002825A (es) Derivados de quinolina como antagonistas de neuropeptido y.
DK1383752T3 (da) Deutererede 3-piperidinopropiophenoner samt lægemidler indeholdende disse forbindelser
AP1780A (en) Use of cox-2 inhibitors for preventing immunodeficiency.
WO2001047913A3 (de) Substituierte n-benzyl-indol-3-yl- glyoxylsäure-derivate antitumorwirkung
ID28510A (id) Formulasi oral yang baru untuk agonis atau antagonis 5-ht4
BR0213293A (pt) Uso de tfpi ou de um análogo de tfpi no tratamento de septicemia
CA2433833A1 (en) Use of flumazenil in developing a drug for the treatment of alcohol dependence
CO5570661A2 (es) Combinaciones que comprenden inhibidores de cox-2 y aspirina
BR0212155A (pt) Composição farmacêutica
BG108144A (bg) Ново приложение
ATE360428T1 (de) Analgetisches arzneimittel
NO20031410L (no) Anvendelse av distamycinderivater for fremstilling av medikamenter
WO2000048445A3 (de) Pharmazeutische zusammensetzung enthaltend desoxypeganin zur behandlung der nikotinabhängigkeit
HUP0301296A2 (hu) Flupirtin alkalmazása degeneratív ízületi fájdalom kezelésére
HK1068606A1 (en) Novel aminobenzoephenones
HK1077215A1 (en) A pharmaceutical composition for treatment of acute myocardial infarction
AU2173101A (en) Use of carboxy compounds such as 2(4-acetoxyphenyl)-2-chloro-N-methyl-ethylammonium chloride as anti-inflammatory agents
TW200509909A (en) Use of organic compounds